Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07403669 · ClinicalTrials.gov registry record · NA
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
A NA study of Heart Failure and Diabetes Mellitus, sponsored by Aventyn.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 5
- Study locations
NCT07403669 is a NA study of Heart Failure and Diabetes Mellitus that is actively recruiting participants, run by Aventyn. The registered enrollment target is 300 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (85% lower). The trial reports 5 study locations across 2 states.
The verdict
NCT07403669, a NA study of Heart Failure and Diabetes Mellitus, is actively recruiting participants, sponsored by Aventyn.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 5
- Study locations
Study Summary
The primary objective of CHAPERONE solution is to evaluate the efficacy of engaging, assessing, and enabling long term treatment strategy with Health Artificial Intelligence (AI) Chatbot, Copilot, Large Language Model (LLM) and vital sign monitoring device in reducing CKM disease burden using an algorithm obtained from biomarkers and diagnostics utilizing remote sensor driven technology tools, care coordination and patient empowerment.
Conditions Studied
Interventions
- OTHER CHAPERONE AI
- DEVICE CKMiq AI
- OTHER Quality of Life
Study Locations (5)
Arizona
- Fountains Family Care - Chandler
- Gilbert Cardiology - Gilbert
- Arizona Heart Foundation - Phoenix
- East Valley Diabetes - San Tan Valley
Other
- Karolinska University Hospital - Stockholm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-10-22 |
| Est. Completion | 2027-04-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07403669
The ClinicalTrials.gov registry entry for NCT07403669 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (85% lower). The listed sponsor is Aventyn, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Heart Failure appearing as the primary indexed condition, and to 3 interventions - of which CHAPERONE AI is the first listed.
NCT07403669 reports 5 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Other.
Frequently Asked Questions
What is clinical trial NCT07403669 about?
NCT07403669 is a clinical study titled "Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment". The primary objective of CHAPERONE solution is to evaluate the efficacy of engaging, assessing, and enabling long term treatment strategy with Health Artificial Intelligence (AI) Chatbot, Copilot, Large Language Model (LLM) and vital sign monitoring device in reducing CKM disease burden using an alg...
What is the current status of trial NCT07403669?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-10-22. Estimated completion is 2027-04-22.
What conditions does trial NCT07403669 study?
This clinical trial studies the following conditions: Heart Failure, Diabetes Mellitus, Kidney Disease, Acute MI.
What interventions are being tested in trial NCT07403669?
The interventions under investigation include: CHAPERONE AI (OTHER), CKMiq AI (DEVICE), Quality of Life (OTHER).
Who is sponsoring clinical trial NCT07403669?
This trial is sponsored by Aventyn, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07403669 being conducted?
This trial has 5 study locations across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.